awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40639927-4D6A1FD3-5066-41FF-9D95-737CC89C70C8
Q40639927-4D6A1FD3-5066-41FF-9D95-737CC89C70C8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40639927-4D6A1FD3-5066-41FF-9D95-737CC89C70C8
High rate of hematological responses to sorafenib in FLT3-ITD acute myeloid leukemia relapsed after allogeneic hematopoietic stem cell transplantation.
P2860
Q40639927-4D6A1FD3-5066-41FF-9D95-737CC89C70C8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40639927-4D6A1FD3-5066-41FF-9D95-737CC89C70C8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
38049c6a33562413ded50660c4ec7fdcf6581f29
P2860
Sorafenib is tolerable and improves clinical outcomes in patients with FLT3-ITD acute myeloid leukemia prior to stem cell transplant and after relapse post-transplant